No abstract available
Keywords:
cardiovascular diseases; diabetes mellitus, type 2; metabolic syndrome; metformin; randomized controlled trial.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-Inflammatory Agents / adverse effects
-
Anti-Inflammatory Agents / therapeutic use*
-
Cardiovascular Agents / adverse effects
-
Cardiovascular Agents / therapeutic use*
-
Cardiovascular Diseases / drug therapy*
-
Cardiovascular Diseases / epidemiology
-
Cardiovascular Diseases / metabolism
-
Cardiovascular Diseases / physiopathology
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Diabetes Mellitus, Type 2 / epidemiology
-
Drug Repositioning*
-
Humans
-
Hypoglycemic Agents / adverse effects
-
Hypoglycemic Agents / therapeutic use*
-
Inflammation Mediators / antagonists & inhibitors
-
Inflammation Mediators / metabolism
-
Metformin / adverse effects
-
Metformin / therapeutic use*
-
Randomized Controlled Trials as Topic
-
Signal Transduction / drug effects
Substances
-
Anti-Inflammatory Agents
-
Cardiovascular Agents
-
Hypoglycemic Agents
-
Inflammation Mediators
-
Metformin